Development and characterization of exendin-4 loaded self-nanoemulsifying system and in vitro evaluation on Caco-2 cell line

被引:6
作者
Aktas, Yesim [1 ]
Celik Tekeli, Merve [1 ,2 ]
Celebi, Nevin [2 ]
机构
[1] Erciyes Univ, Fac Pharm, Dept Pharmaceut Technol, Kayseri, Turkey
[2] Gazi Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06330 Ankara, Turkey
关键词
Exendin-4; self-nanoemulsifying drug delivery system; oral delivery; lipolysis; intestinal permeability; EMULSIFYING DRUG-DELIVERY; ORAL DELIVERY; VIVO EVALUATION; EXENATIDE; NANOPARTICLES; LIPOLYSIS; INSULIN; SNEDDS; SEDDS; BIOAVAILABILITY;
D O I
10.1080/02652048.2019.1692945
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Aim: Aim of this study was to develop exendin-4 and exendin-4/chymostatin loaded self-nanoemulsifying drug delivery system (SNEDDS). Methods: Surfactants and co-surfactants were mixed, oil phase containing exendin-4 or exendin-4/chymostatin was added dropwise for SNEDDS. Short term physical stability test was performed prior to the release, lipolysis and permeability studies. Results: SNEDDS containing ethyl oleate: Cremophor EL(R): Labrasol(R): propylene glycole (15:42.5:21.25: 21.25) were selected for in vitro release and intestinal permeability studies for suitable parameters and physical stability test results. SNEDDS were obtained which yielded Grade B nanoemulsions having droplet size below 25 nm. In vitro release studies showed that 73.79% of the peptide was released for 2 h at pH 6.8. Both exendin-4 and exendin-4/chymostatin loaded SNEDDS were non-toxic to Caco-2 cells. Permeability coefficients of both exendin-4 loaded SNEDDS and exendin-4/chymostatin loaded SNEDDS were higher than exendin-4 solution. Conclusions: Intestinal permeability of exendin-4 has been improved by SNEDDS formulations.
引用
收藏
页码:41 / 51
页数:11
相关论文
共 29 条
[1]   Comparison between lipolysis and compendial dissolution as alternative techniques for the in vitro characterization of α-tocopherol self-emulsified drug delivery systems (SEDDS) [J].
Ali, Hazem ;
Nazzal, Mahmoud ;
Zaghloul, Abdel-Azim A. ;
Nazzal, Sami .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 352 (1-2) :104-114
[2]  
Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc11-S062, 10.2337/dc11-S011, 10.2337/dc12-s011, 10.2337/dc13-S011, 10.2337/dc10-S011, 10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc12-s064]
[3]   Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems [J].
Balakrishnan, Prabagar ;
Lee, Beom-Jin ;
Oh, Dong Hoon ;
Kim, Jong Oh ;
Lee, Young-Im ;
Kim, Dae-Duk ;
Jee, Jun-Pil ;
Lee, Yong-Bok ;
Woo, Jong Soo ;
Yong, Chul Soon ;
Choi, Han-Gon .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 374 (1-2) :66-72
[4]  
Bhansali A., 2010, J ASSOC PHYSICIAN I, V58, P10
[5]  
Celik-Tekeli M., 2018, 12 INT S PHARM SCI I, P310
[6]   Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules [J].
Chen, Mei-Chin ;
Mi, Fwu-Long ;
Liao, Zi-Xian ;
Hsiao, Chun-Wen ;
Sonaje, Kiran ;
Chung, Min-Fan ;
Hsu, Li-Wen ;
Sung, Hsing-Wen .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (06) :865-879
[7]   Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS [J].
Christophersen, Philip Carsten ;
Christiansen, Martin Lau ;
Holm, Rene ;
Kristensen, Jakob ;
Jacobsen, Jette ;
Abrahamsson, Bertil ;
Mullertz, Anette .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 57 :232-239
[8]   Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT [J].
Chuang, Er-Yuan ;
Giang Thi Ha Nguyen ;
Su, Fang-Yi ;
Lin, Kun-Ju ;
Chen, Chiung-Tong ;
Mi, Fwu-Long ;
Yen, Tzu-Chen ;
Juang, Jyuhn-Huarng ;
Sung, Hsing-Wen .
BIOMATERIALS, 2013, 34 (32) :7994-8001
[9]   Permeation of Insulin, Calcitonin and Exenatide across Caco-2 Monolayers: Measurement Using a Rapid, 3-Day System [J].
Gupta, Vivek ;
Doshi, Nishit ;
Mitragotri, Samir .
PLOS ONE, 2013, 8 (02)
[10]   Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs [J].
Gursoy, RN ;
Benita, S .
BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (03) :173-182